Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for Microvascular Function in Type 2 Diabetes
NCT00931879Phase 4Completed
- Sponsor
- Eastern Virginia Medical School
- Start
- Oct 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in diabetic neuropathy, hypertriglyceridemia, sponsored by Eastern Virginia Medical School. Started Oct 2009; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
diabetic neuropathyhypertriglyceridemia
Beyond the preview
Go deeper on NCT00931879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931879.